Cooper Current Ratio 2010-2024 | COO
Current and historical current ratio for Cooper (COO) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Cooper current ratio for the three months ending January 31, 2024 was 1.86.
| Cooper Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-01-31 |
$1.79B |
$0.97B |
1.86 |
| 2023-10-31 |
$1.71B |
$0.97B |
1.76 |
| 2023-07-31 |
$1.71B |
$0.99B |
1.72 |
| 2023-04-30 |
$1.60B |
$0.95B |
1.69 |
| 2023-01-31 |
$1.58B |
$0.92B |
1.72 |
| 2022-10-31 |
$1.53B |
$1.28B |
1.20 |
| 2022-07-31 |
$1.60B |
$1.38B |
1.16 |
| 2022-04-30 |
$1.74B |
$1.65B |
1.05 |
| 2022-01-31 |
$1.70B |
$1.66B |
1.02 |
| 2021-10-31 |
$1.47B |
$0.73B |
2.00 |
| 2021-07-31 |
$1.48B |
$1.06B |
1.39 |
| 2021-04-30 |
$1.32B |
$0.99B |
1.33 |
| 2021-01-31 |
$1.30B |
$0.96B |
1.35 |
| 2020-10-31 |
$1.27B |
$1.00B |
1.27 |
| 2020-07-31 |
$1.32B |
$1.13B |
1.17 |
| 2020-04-30 |
$1.17B |
$1.03B |
1.14 |
| 2020-01-31 |
$1.15B |
$1.07B |
1.08 |
| 2019-10-31 |
$1.16B |
$1.11B |
1.05 |
| 2019-07-31 |
$1.15B |
$0.89B |
1.29 |
| 2019-04-30 |
$1.14B |
$0.94B |
1.21 |
| 2019-01-31 |
$1.19B |
$0.94B |
1.27 |
| 2018-10-31 |
$1.09B |
$0.54B |
2.03 |
| 2018-07-31 |
$1.19B |
$0.46B |
2.58 |
| 2018-04-30 |
$1.27B |
$0.46B |
2.76 |
| 2018-01-31 |
$1.18B |
$0.42B |
2.83 |
| 2017-10-31 |
$0.95B |
$0.40B |
2.41 |
| 2017-07-31 |
$0.93B |
$0.37B |
2.51 |
| 2017-04-30 |
$0.96B |
$0.34B |
2.79 |
| 2017-01-31 |
$0.88B |
$0.52B |
1.71 |
| 2016-10-31 |
$0.94B |
$0.54B |
1.73 |
| 2016-07-31 |
$0.93B |
$0.32B |
2.90 |
| 2016-04-30 |
$0.92B |
$0.32B |
2.84 |
| 2016-01-31 |
$0.85B |
$0.35B |
2.43 |
| 2015-10-31 |
$0.84B |
$0.57B |
1.48 |
| 2015-07-31 |
$0.82B |
$0.53B |
1.54 |
| 2015-04-30 |
$0.80B |
$0.54B |
1.49 |
| 2015-01-31 |
$0.79B |
$0.38B |
2.06 |
| 2014-10-31 |
$0.79B |
$0.44B |
1.79 |
| 2014-07-31 |
$0.90B |
$0.30B |
3.01 |
| 2014-04-30 |
$0.77B |
$0.27B |
2.89 |
| 2014-01-31 |
$0.70B |
$0.27B |
2.61 |
| 2013-10-31 |
$0.75B |
$0.32B |
2.33 |
| 2013-07-31 |
$0.71B |
$0.25B |
2.83 |
| 2013-04-30 |
$0.68B |
$0.23B |
2.95 |
| 2013-01-31 |
$0.68B |
$0.23B |
3.01 |
| 2012-10-31 |
$0.66B |
$0.26B |
2.51 |
| 2012-07-31 |
$0.63B |
$0.23B |
2.71 |
| 2012-04-30 |
$0.58B |
$0.23B |
2.53 |
| 2012-01-31 |
$0.56B |
$0.21B |
2.69 |
| 2011-10-31 |
$0.54B |
$0.27B |
2.02 |
| 2011-07-31 |
$0.54B |
$0.24B |
2.29 |
| 2011-04-30 |
$0.54B |
$0.21B |
2.61 |
| 2011-01-31 |
$0.50B |
$0.19B |
2.71 |
| 2010-10-31 |
$0.49B |
$0.20B |
2.46 |
| 2010-07-31 |
$0.49B |
$0.22B |
2.19 |
| 2010-04-30 |
$0.49B |
$0.21B |
2.37 |
| 2010-01-31 |
$0.50B |
$0.18B |
2.78 |
| 2009-10-31 |
$0.50B |
$0.18B |
2.87 |
| 2009-07-31 |
$0.52B |
$0.21B |
2.44 |
| 2009-04-30 |
$0.53B |
$0.21B |
2.47 |
| 2009-01-31 |
$0.54B |
$0.25B |
2.11 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.970B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
